Soleimani Dodaran, M., Borgoni, S., Sofyalı, E., Verschure, P. J., Wiemann, S., Moerland, P. D., & van Kampen, A. H. C. (2020). Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancer. BMC Cancer.
Citação norma ChicagoSoleimani Dodaran, Maryam, Simone Borgoni, Emre Sofyalı, Pernette J. Verschure, Stefan Wiemann, Perry D. Moerland, and Antoine H. C. van Kampen. "Candidate Methylation Sites Associated With Endocrine Therapy Resistance in ER+/HER2- Breast Cancer." BMC Cancer 2020.
Citação norma MLASoleimani Dodaran, Maryam, et al. "Candidate Methylation Sites Associated With Endocrine Therapy Resistance in ER+/HER2- Breast Cancer." BMC Cancer 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.